Skip to main content
Premium Trial:

Request an Annual Quote

Molecular Devices Stock Surges 13.8 Percent on Profitability News

NEW YORK, Oct. 28 (GenomeWeb News) - Shares in Molecular Devices were up 11.7 percent, or $2.30, at $21.94, in mid-afternoon trading after the company announced profitable third-quarter results yesterday.


As GenomeWeb News reported earlier, Molecular Devices had an 8.8-percent increase in third-quarter revenue from last year and a $4.6-million profit. The company posted a loss last year.


While R&D spending remained flat, demand remained strong for some product lines, the company said.

The Scan

Not Yet a Permanent One

NPR says the lack of a permanent Food and Drug Administration commissioner has "flummoxed" public health officials.

Unfair Targeting

Technology Review writes that a new report says the US has been unfairly targeting Chinese and Chinese-American individuals in economic espionage cases.

Limited Rapid Testing

The New York Times wonders why rapid tests for COVID-19 are not widely available in the US.

Genome Research Papers on IPAFinder, Structural Variant Expression Effects, Single-Cell RNA-Seq Markers

In Genome Research this week: IPAFinder method to detect intronic polyadenylation, influence of structural variants on gene expression, and more.